Drugs / recombinant human activated protein C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00741013 | Mar 2007 → Mar 2008 | pneumonitis | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human activated protein C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00741013 ↗ |
| Known as | rhAPC | “recombinant human activated protein C (rhAPC)” PMID 19574441 ↗ Jul 2009 |
| Modality | Protein / enzyme biologic | “recombinant human activated protein C (rhAPC)” PMID 19574441 ↗ Jul 2009 |
| Route | Intravenous | “recombinant human activated protein C IV” NCT00741013 ↗ |